Tuesday 21st March 2017
News
Tuesday 7th March 2017
Prescription Charges Coalition Survey
The Prescription Charges Coalition has launched a survey looking at the ways in which prescription charges affect the lives of people in England with long-term conditions such as Scleroderma and Raynaud’s.
Wednesday 30th March 2016
Halfway Point Marked in Scleroderma Patient Enrolment for Cytori's ECCS-50 Phase 3 Trial
Cytori Therapeutics has enrolled and treated its 40th patient with scleroderma in the Phase 3 STAR clinical trial for ECCS-50, marking 50 percent of target enrollment.